Bolt Biotherapeutics Inc (BOLT)

May 22, 2025

Lake Street Capital Begins Coverage on Bolt Biotherapeutics (NASDAQ:BOLT) - Defense World

May 22, 2025

May 20, 2025

Lake Street Initiates Coverage of Bolt Biotherapeutics (BOLT) with Buy Recommendation - Nasdaq

May 20, 2025

May 20, 2025

BOLT: Lake Street Initiates Coverage on Bolt Biotherapeutics wit - GuruFocus

May 20, 2025

May 20, 2025

BOLT: Lake Street Initiates Coverage on Bolt Biotherapeutics with Buy Rating | BOLT Stock News - GuruFocus

May 20, 2025

May 20, 2025

Lake Street Begins Coverage of Bolt Biotherapeutics (BOLT) with Bullish Outlook | BOLT Stock News - GuruFocus

May 20, 2025

May 16, 2025

Leerink Partnrs Has Optimistic Outlook of BOLT Q2 Earnings - Defense World

May 16, 2025

May 15, 2025

Stifel Nicolaus Lowers Bolt Biotherapeutics (NASDAQ:BOLT) Price Target to $1.00 - Defense World

May 15, 2025

May 14, 2025

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 14, 2025

May 13, 2025

BOLT Stock Target Price Revised to $1 Amid Recent Developments | - GuruFocus

May 13, 2025

May 13, 2025

BOLT: Stifel Lowers Price Target on Bolt Biotherapeutics, Mainta - GuruFocus

May 13, 2025

May 13, 2025

Bolt Biotherapeutics Reports Q1 2025 Financial Results - TipRanks

May 13, 2025

May 12, 2025

BOLT Exceeds Q1 Revenue Expectations with Higher Earnings | BOLT Stock News - GuruFocus

May 12, 2025

May 12, 2025

Bolt Biotherapeutics Inc.: Q1 Earnings Snapshot - San Antonio Express-News

May 12, 2025

May 12, 2025

Bolt Biotherapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

May 12, 2025

Bolt Biotherapeutics Inc (BOLT) Q1 2025 Earnings: EPS of -$0.29 - GuruFocus

May 12, 2025

May 12, 2025

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 12, 2025

May 12, 2025

Bolt Biotherapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025

May 11, 2025

Bolt Biotherapeutics (BOLT) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 10, 2025

Biotech Alert: Searches spiking for these stocks today - Yahoo Finance

May 10, 2025

May 08, 2025

BOLT: Surge in Interest for Bolt Biotherapeutics Amid Key Develo - GuruFocus

May 08, 2025

May 08, 2025

Bolt Biotherapeutics (BOLT) to Host Webcast on Clinical Study an - GuruFocus

May 08, 2025

May 08, 2025

Bolt Biotherapeutics (BOLT) to Host Webcast on Clinical Study and Financial Updates | BOLT Stock News - GuruFocus

May 08, 2025

May 08, 2025

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates - The Manila Times

May 08, 2025

May 08, 2025

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 ... - Eagle-Tribune

May 08, 2025

May 04, 2025

Bolt Biotherapeutics, Inc. (BOLT) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire

May 04, 2025

May 01, 2025

Bolt Biotherapeutics amends bylaws, adjusts quorum requirement - Investing.com Australia

May 01, 2025

Apr 30, 2025

Innovative Advances in Bolt Biotherapeutics (BOLT) Cancer Therap - GuruFocus

Apr 30, 2025

Apr 30, 2025

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025 - The Manila Times

Apr 30, 2025

Apr 29, 2025

Bolt Biotherapeutics amends bylaws, adjusts quorum requirement By Investing.com - Investing.com India

Apr 29, 2025

Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Apr 26, 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 - The Manila Times

Apr 26, 2025

Apr 25, 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Esca - GuruFocus

Apr 25, 2025

Apr 25, 2025

Bolt Biotherapeutics reports positive Phase 1 cancer trial results By Investing.com - Investing.com India

Apr 25, 2025

Apr 25, 2025

Bolt Biotherapeutics Reports Positive Phase 1 Results for BDC-3042, Demonstrating Safety and Anti-Tumor Activity in Cancer Patients - Nasdaq

Apr 25, 2025

Apr 25, 2025

Breakthrough Cancer Drug Achieves 80% Disease Control: Phase 1 Trial Reveals Promising NSCLC Results - Stock Titan

Apr 25, 2025

Apr 17, 2025

Bolt Biotherapeutics modifies quorum requirements By Investing.com - Investing.com Canada

Apr 17, 2025

Apr 16, 2025

Bolt Biotherapeutics modifies quorum requirements - Investing.com

Apr 16, 2025

Apr 12, 2025

BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit - marketscreener.com

Apr 12, 2025

Apr 10, 2025

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025

Apr 08, 2025

Sept. 3rd Deadline ALERT: Investors Who Lost More Than $100,000 With Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Shares Should Contact the Shareholders Foundation - ACCESS Newswire

Apr 08, 2025

Apr 08, 2025

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 08, 2025

Apr 07, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Bolt Biotherapeutics, Inc. (BOLT) - ACCESS Newswire

Apr 07, 2025

Apr 04, 2025

Bolt Biotherapeutics stock hits 52-week low at $0.38 By Investing.com - Investing.com UK

Apr 04, 2025

Apr 03, 2025

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 03, 2025

Mar 29, 2025

What is HC Wainwright’s Estimate for BOLT Q1 Earnings? - Defense World

Mar 29, 2025

Mar 28, 2025

What is Leerink Partnrs’ Forecast for BOLT Q1 Earnings? - Defense World

Mar 28, 2025

Mar 28, 2025

Q3 Earnings Forecast for BOLT Issued By HC Wainwright - Defense World

Mar 28, 2025